GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Cardlytics Inc (NAS:CDLX) » Definitions » Equity-to-Asset

Cardlytics (Cardlytics) Equity-to-Asset : 0.24 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cardlytics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cardlytics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $134.8 Mil. Cardlytics's Total Assets for the quarter that ended in Dec. 2023 was $574.1 Mil. Therefore, Cardlytics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.24.

The historical rank and industry rank for Cardlytics's Equity-to-Asset or its related term are showing as below:

CDLX' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.5   Med: 0.31   Max: 0.64
Current: 0.24

During the past 9 years, the highest Equity to Asset Ratio of Cardlytics was 0.64. The lowest was -2.50. And the median was 0.31.

CDLX's Equity-to-Asset is ranked worse than
78.87% of 1060 companies
in the Media - Diversified industry
Industry Median: 0.52 vs CDLX: 0.24

Cardlytics Equity-to-Asset Historical Data

The historical data trend for Cardlytics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardlytics Equity-to-Asset Chart

Cardlytics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.64 0.37 0.55 0.31 0.24

Cardlytics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.34 0.37 0.36 0.24

Competitive Comparison of Cardlytics's Equity-to-Asset

For the Advertising Agencies subindustry, Cardlytics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardlytics's Equity-to-Asset Distribution in the Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Cardlytics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cardlytics's Equity-to-Asset falls into.



Cardlytics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cardlytics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=134.798/574.144
=0.23

Cardlytics's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=134.798/574.144
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardlytics  (NAS:CDLX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cardlytics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cardlytics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardlytics (Cardlytics) Business Description

Traded in Other Exchanges
Address
675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, GA, USA, 30308
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
Executives
Clifford Sosin 10 percent owner 8 WRIGHT STREET, 1ST FL, WESTPORT CT 06880
Karim Saad Temsamani director, officer: Chief Executive Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Nicholas Hollmeyer Lynton officer: Chief Legal & Privacy Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Alex Mishurov director C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, SUITE 6000, ATLANTA GA 30308
Scott A Hill director INTERCONTINENTALEXCHANGE, INC., 2100 RIVEREDGE PKWY. STE. 500, ATLANTA GA 30328
Alexis Desieno officer: Chief Financial Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Andrew Christiansen officer: Chief Financial Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Chris Suh director C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, STE 6000, ATLANTA GA 30308
Jessica Jensen director C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Amit Gupta officer: Chief Operating Officer C/O CARDLYTICS, INC, 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
John V Balen director
Scott D. Grimes director, officer: Chief Executive Officer CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Lynne Marie Laube director, officer: Chief Operating Officer C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Kirk Somers officer: Chief Legal & Privacy Officer
S Aimee Lapic director 2101 WEBSTER ST #1650, OAKLAND CA 94612